Exercise of Nil Cost Options under PSP

RNS Number : 8592O
Assura PLC
11 February 2021
 

11 February 2021

 

Assura plc

 

Exercise of Nil Cost Options under PSP

 

Assura plc ("Assura"), the leading primary care property investor and developer announces that on 9 February 2021, Jayne Cottam exercised her 2017 PSP awards.

 

The table below shows the number of shares vesting to Mrs Cottam, the number of shares sold to satisfy income tax and national insurance liabilities, the number of shares received following the sale and the resultant shareholding of Ms Cottam and her persons closely associated ("PCAs").

 


Number of

Shares awarded

Number of shares sold to satisfy income tax and national insurance liabilities

Shares retained

Shareholding of PDMR and PCAs post exercise

 

Jayne Cottam (CFO)

167,681

(78,810)

88,871

266,537

 

The Remuneration Committee of Assura had agreed that sufficient shares may be sold by PDMRs to cover the arising income tax and national insurance liabilities. The relevant market price for taxation purposes is £0. 7376 per share.

 

Following the allotment, Mrs Cottam transferred 88,871 shares to her husband. The total beneficial holding of Ms Cottam and her PCAs remains the same.

The Notification of Dealing Form for the PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

 

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jayne Cottam

2

Reason for the notification

 

a)

Position/status

 

CFO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

 Vesting of share awards under PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

 

167,681

 

 

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

N/A

e)

Date of the transaction

 

9 February 2021

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Sale of 7 8,810 shares to satisfy tax and national insurance liabilities.

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.7376 GBP

 

 

78,810

 

 

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.7376 GBP

 

 

78,810

 

£58,130.25

e)

Date of the transaction

 

10 February 2021

f)

Place of the transaction

 

XLON

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

Transfer of 8 8,871 shares to Mrs C ottam 's h usband .

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.7376 GBP

 

 

88,871

 

 

 

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.7376 GBP

 

 

88,871

 

£65,551.25

e)

Date of the transaction

 

10 February 2021

f)

Place of the transaction

 

XLON

 

 

 

- Ends -

 

For more information, please contact:

 

Assura plc
Orla Ball, Company Secretary
David Purcell, Head of Investor Relations

Tel: 01925 420680
E mail: Investor@assura.co.uk

 

Finsbury

Gordon Simpson
James Thompson

 

Tel: 0207 251 3801
Email: Assura@Finsbury.com

 

Notes to Editors

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

Assura plc LEI code: 21380026T19N2Y52XF72

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUWPPUPGGQG

Companies

Assura (AGR)
UK 100

Latest directors dealings